Budget vs premium
Gala vs SnagRx: Which Costs Less Over 12 Months? (2026)
Compare Gala and SnagRx on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.7 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Two platforms, one drug class, and a difference in annual cost most people do not notice until month four. That is the Gala versus SnagRx question.
Gala costs 2.5x more per month than SnagRx once promotional pricing is out of the picture ($249/mo against $99/mo). Over a year that gap compounds into real money, and the question is what it buys.
What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. Where a figure is not published, that is stated rather than estimated.
The short answer
- Lowest 12-month cost
- SnagRx — $828 against $2,148 at Gala, on each provider's own best published pricing.
- Most predictable bill
- SnagRx — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- SnagRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Most support included
- Gala — Provider check-ins and dose monitoring included.
Side-by-side comparison
Every figure below is the provider's own published number. The blank spaces are theirs, not ours.
| Gala | SnagRx | |
|---|---|---|
| Advertised price | From $249/mo, as low as $179/mo on longer plans | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan |
| Rate after promotions | $249/mo | $99/mo |
| Pricing structure | Cheaper per month the longer you commit | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| State coverage | Not published | 48 states |
| How fast you start | Fully online, no in-office visits | 5-minute intake, clinician review typically within 5 hours and always within 24 |
| Membership fee | None | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 2,870 | 9,860 |
| eRxDoctor score | 7.7/10 | 7.5/10 |
The real cost: six months and twelve
Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| Gala | SnagRx | |
|---|---|---|
| First month | $249 | $99 |
| Months 2 onward | $249/mo | $99/mo |
| 6-month total | $1,494 | $594 |
| 12-month total | $2,988 | $1,188 |
| Best published plan | longer-term plan at $179/mo — $2,148/yr | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr |
The twelve-month spread is $1,320. That is the number to hold Gala against: it has to justify roughly $110 extra every month.
What the price difference actually buys
Gala charges $249/mo where SnagRx charges $99/mo. A premium is defensible only if it maps to something specific, so here is what Gala puts behind it: provider check-ins and dose monitoring included, and home delivery.
SnagRx counters with the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly, and the thing it asks you to accept in return: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
The premium buys attention. If you expect to need it — first GLP-1, side effects you will want triaged quickly, a history of stalling around week ten — it is money well spent. If you do not, it is not.
Inside the Gala program
Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery.
Intake is fully online, no in-office visits. Fulfillment is home delivery. The commercial terms are cheaper per month the longer you commit, published upfront.
Behind the prescription sits provider check-ins and dose monitoring included. Available medication: compounded semaglutide and compounded tirzepatide.
Gala pros
- Provider check-ins and dose monitoring included
- Direct-pay model, no insurance or prior authorizations needed
- Fully online, no in-office visits required
Gala cons
- Higher entry price than several compounded competitors
- Lower long-term pricing requires a multi-month commitment
Read next to SnagRx, the weak point: the entry price sits above most compounded competitors unless you commit to a longer term.
A closer look at SnagRx
SnagRx positions itself on the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly. SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping.
Practically: 5-minute intake, clinician review typically within 5 hours and always within 24, free next-day UPS or FedEx in temperature-controlled packaging, and a pricing model that is flat rate at every dose.
On the clinical side, 1:1 nursing staff plus a secure patient portal for refills and dose changes, prescribing compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Clinician review typically within 5 hours; next-day temperature-controlled shipping
- Full refund if the prescription is declined, plus a 6-month weight-loss guarantee (terms apply)
- Bottom-of-market pricing on the annual plan: $69/mo semaglutide, $119/mo tirzepatide
- Price locked flat at every dose and at renewal — no re-pricing during titration
SnagRx cons
- Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
- The advertised $69 and $119 rates require the 12-month plan; month-to-month is $99 and $149
- Heavy urgency marketing, including a countdown timer on the pricing page
The reservation worth holding, particularly next to Gala: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
Which one fits which patient
Choose Gala if:
- delivery works the way you want it to: home delivery
- the level of clinical contact suits you: provider check-ins and dose monitoring included
- you want to start on their timeline: fully online, no in-office visits
- you are willing to commit for a term in exchange for a lower effective rate (longer-term plan at $179/mo)
Choose SnagRx if:
- delivery works the way you want it to: free next-day UPS or FedEx in temperature-controlled packaging
- you want tirzepatide available without changing provider later
- you are willing to commit for a term in exchange for a lower effective rate (12-month semaglutide plan at $69/mo ($828 a year))
- the monthly rate is the constraint — $99/mo against $249/mo
The trade-offs, stated plainly
On price. SnagRx is the cheaper program at $99/mo against $249/mo. What SnagRx gives up for that is the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149; what Gala charges for is a direct-pay model with dose monitoring included rather than sold as an add-on.
On commitment. Gala rewards a longer commitment (longer-term plan at $179/mo), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On predictability. Cheaper per month the longer you commit at Gala, against flat rate at every dose at SnagRx. The more predictable structure is worth a premium to anyone who has been surprised by a telehealth invoice before.
On access. Gala advertises fully online, no in-office visits and home delivery; SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24 and free next-day UPS or FedEx in temperature-controlled packaging. Coverage differs too — not published against 48 states — which decides the question before price does if you are in a restricted state.
The clinical evidence, separated from the marketing
Weight loss percentages quoted in telehealth marketing come from trials neither Gala nor SnagRx ran. Here is the source material, and what regulators say alongside it.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
Use it as the floor for the conversation with whichever prescriber you end up with, rather than as a reason to pick one platform over the other.
Gala vs SnagRx: common questions
Which is cheaper to start, Gala or SnagRx?
SnagRx, at $99 against $249. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which costs less over a year, Gala or SnagRx?
SnagRx, at roughly $828 for twelve months against $2,148 at Gala, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Is SnagRx cheaper than Gala?
Yes, on the ongoing rate. SnagRx runs $99/mo once promotional pricing ends, against $249/mo at Gala — a difference of 2.5x. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
How fast can I start with Gala compared with SnagRx?
Gala advertises fully online, no in-office visits, with home delivery. SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24, with free next-day UPS or FedEx in temperature-controlled packaging. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Does Gala or SnagRx offer tirzepatide?
SnagRx does, at $149/mo. Gala publishes compounded semaglutide and compounded tirzepatide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
Do Gala and SnagRx prescribe the same medication?
Both dispense compounded GLP-1 preparations. Gala lists compounded semaglutide and compounded tirzepatide and SnagRx lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.
Is Gala or SnagRx better for a first GLP-1 prescription?
For a first prescription, weight support over price. Gala offers more contact (provider check-ins and dose monitoring included), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
The verdict
On the numbers, SnagRx wins the year: $828 against $2,148. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Where Gala justifies itself is a direct-pay model with dose monitoring included rather than sold as an add-on. Where it does not is anywhere the extra spend buys features you will never open.
Get the maintenance-dose price in writing from whichever one you pick. That single question prevents most of the regret in this category.
Keep comparing
- Gala vs RefillsBudget vs premium
- Gala vs EmbodyBudget vs premium
- SnagRx vs TMatesBudget vs premium
- SnagRx vs Elevate HealthHead to head
- TrimRx vs LIV BodyBudget vs premium
- Measured vs He & She MDBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Gala or SnagRx, and does not sell treatment. Read our ranking methodology.